Proto Labs (PRLB) EBT Margin (2011 - 2026)

Proto Labs has disclosed EBT Margin across 16 years of filings, most recently posting 8.44% for Q2 2026.

• In Q2 2026, EBT Margin rose 350.0% year-over-year to 8.44%; the TTM figure through Jun 2026 stood at 7.55% (up 318.0% YoY), while the FY2025 annual figure was 5.83%, up 90.0% from the prior year.
• EBT Margin came in at 8.44% for Q2 2026 at Proto Labs, up from 8.12% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 8.44% in Q2 2026 to a low of 100.95% in Q4 2022.
• Average EBT Margin over 5 years is 0.25%, with a median of 5.92% recorded in 2024.
• Year-over-year, EBT Margin sank 11141 bps in 2022 and soared 10890 bps in 2023.
• Over 5 years, EBT Margin stood at 100.95% in 2022, then soared by 108 bps to 7.95% in 2023, then slumped by 103 bps to 0.23% in 2024, then surged by 2679 bps to 5.97% in 2025, then jumped by 41 bps to 8.44% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 8.44% in Q2 2026, 8.12% in Q1 2026, and 5.97% in Q4 2025.